Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Penelope J. Hallett, Ph.D.
- Study ID
- NCT06422208
- Phase
- PHASE1
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 55 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Autologous midbrain dopamine neurons — BIOLOGICALThe autologous midbrain dopamine neurons are an experimental cryopreserved cell product derived from human autologous induced pluripotent stem cells. The autologous midbrain dopamine neurons are surgically administered into the putamen. Six participants received unilateral transplantation into one putamen. Six participants will receive bilateral transplantation into both putamina during a single surgical session.
Study Details
This research study is evaluating an investigational cell product called autologous induced pluripotent stem cell (iPSC)-derived dopamine neurons. This research study is a single-center Phase 1/2a clinical trial, which will test the safety of injecting the investigational cell product into the brain of subjects with Parkinson's disease.
Key Dates
- First listed
- May 20, 2024
- Start date
- Aug 7, 2024
- Status verified
- Sep 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 12 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Autologous midbrain dopamine neurons
Primary Outcome Measure
Safety: number and severity of adverse events and serious adverse events [ Time Frame: Baseline to 12 months post-transplant and baseline to 18 months post-transplant ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brigham & Women's Hospital | Boston | Massachusetts | 02215 | - |
Find similar trials in Boston, MA
By condition
By specialty
By research site
Related Studies
- Natural History Study of SynucleinopathiesRecruiting · NYU Langone Health · Boston, Massachusetts
- North American Prodromal Synucleinopathy ConsortiumEnrolling By Invitation · Washington University School of Medicine · Sun City, Arizona
- Abbott DBS Post-Market Study of Outcomes for Indications Over TimeRecruiting · Abbott Medical Devices · Tampa, Florida
- Cortical-Basal Ganglia Speech NetworksRecruiting · Massachusetts General Hospital · Boston, Massachusetts